// insider-profile
Hirawat Samit
This page tracks every SEC Form 4 filing by Hirawat Samit, EVP,Chief Med.Offr.,Drug Dev.: 43 transactions in total, including 3 open-market purchases and 0 sales. Each record is parsed directly from the original filing, with amendments reconciled so a corrected filing never double-counts.
// activity-summary
Recent insider activity is bullish. Over the last 30 days, 2 insiders purchased shares. Buying was led by Hirawat Samit.
// track-record
Most active in
Transaction History
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | Hirawat Samit | PCRX | Award | 10,891 | $0.00 | $0K |
| Jun 10, 2026 | Hirawat Samit | PCRX | Award | 6,405 | $0.00 | $0K |
| Jan 27, 2026 | Hirawat Samit | PCRX | Award | 39,291 | $0.00 | $0K |
| Apr 25, 2025 | Hirawat Samit | BMY | Purchase | 4,250 | $47.58 | $202K |
| Mar 10, 2025 | Hirawat Samit | BMY | Tax Withholding | 2,013 | $63.11 | $127K |
38 more transactions hidden
Free account · No credit card required
Building something? Get API access →
// how to read this
Reading an insider's Form 4 history
Corporate insiders — directors, officers, and holders of more than 10% of a company's stock — must report their trades to the SEC on Form 4 within two business days. Looking at one insider's filings over time shows whether they tend to buy on the open market (a discretionary use of their own money, generally the strongest signal), sell, or simply receive and exercise equity awards as compensation.
The track record above measures how this insider's past open-market purchases performed in the months after each filing. Trades made under a pre-scheduled Rule 10b5-1 plan are flagged because they carry no timing signal. To pull any insider's full history programmatically, see the insider trading API or our guide to reading Form 4 filings.